Lifeward Ltd. (LFWD) vs NeuroOne Medical Technologies Corporation (NMTC)

A side-by-side comparison of Lifeward Ltd. and NeuroOne Medical Technologies Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LFWD vs NMTC

growth of $100 · dividends reinvested · last 9y
LFWD -99.7% (-48.0%/yr)NMTC -98.5% (-37.1%/yr)NMTC compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $1002020202220242026$0$2
LFWD NMTC

LFWD vs NMTC: by the numbers

  • •LFWD is the larger company ($11M vs $10M market cap).
  • •Both run net losses; NMTC's is the smaller (-71.51% vs -141.28% net margin).
  • •LFWD grew revenue faster over the past five years (38.07% vs 37.21% CAGR).

Metrics side by side

Valuation

MetricLFWDNMTC
P/S ratio0.481.00
P/B ratio0.862.66

Profitability

MetricLFWDNMTC
Gross margin35.95%67.30%
Operating margin-76.66%-34.94%
Net margin-141.28%-71.51%
ROE-252.37%-189.76%
ROIC-95.42%-183.45%

Growth (annualized)

MetricLFWDNMTC
Revenue CAGR (5Y)38.07%37.21%
Total return CAGR (5Y)-43.18%-46.02%

Frequently asked

Which has grown faster, LFWD or NMTC?
Over the past five years, LFWD grew revenue faster — LFWD at a 38.07% CAGR versus NMTC at 37.21%.
How have LFWD and NMTC total returns compared?
Over the past 5 years, LFWD delivered -43.18% and NMTC delivered -46.02% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.